Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Breast cancer in the personal genomics era.

Ellsworth RE, Decewicz DJ, Shriver CD, Ellsworth DL.

Curr Genomics. 2010 May;11(3):146-61. doi: 10.2174/138920210791110951.

2.

Translating genomics in cancer care.

Bombard Y, Bach PB, Offit K.

J Natl Compr Canc Netw. 2013 Nov;11(11):1343-53. Review.

PMID:
24225968
3.
4.

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Weitzel JN, Blazer KR, MacDonald DJ, Culver JO, Offit K.

CA Cancer J Clin. 2011 Sep-Oct;61(5):327-59. doi: 10.3322/caac.20128. Epub 2011 Aug 19. Review.

5.

Direct-to-consumer personal genome testing and cancer risk prediction.

Bellcross CA, Page PZ, Meaney-Delman D.

Cancer J. 2012 Jul-Aug;18(4):293-302. doi: 10.1097/PPO.0b013e3182610e38. Review.

PMID:
22846729
6.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
7.

American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

American Society of Clinical Oncology.

J Clin Oncol. 2003 Jun 15;21(12):2397-406. Epub 2003 Apr 11.

PMID:
12692171
8.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

9.

Advances in breast cancer: pathways to personalized medicine.

Olopade OI, Grushko TA, Nanda R, Huo D.

Clin Cancer Res. 2008 Dec 15;14(24):7988-99. doi: 10.1158/1078-0432.CCR-08-1211. Review.

10.

Influence of genomics on adjuvant treatments for pre-invasive and invasive breast cancer.

Abu-Khalf M, Pusztai L.

Breast. 2013 Aug;22 Suppl 2:S83-7. doi: 10.1016/j.breast.2013.07.015. Review.

PMID:
24074799
11.

[Genomic basis for breast cancer: advances in personalized medicine].

Hidalgo-Miranda A, Jiménez-Sánchez G.

Salud Publica Mex. 2009;51 Suppl 2:s197-207. Review. Spanish.

12.

The Impact of the Emerging Genomics Data on the Management of Agerelated Phenotypes in the Context of Cellular Senescence.

Montesanto A, Geracitano S, Garasto S, Fusco S, Lattanzio F, Passarino G, Corsonello A.

Curr Drug Targets. 2016;17(4):428-38. Review.

PMID:
25601329
13.

Integration of genomics in cancer care.

Santos EM, Edwards QT, Floria-Santos M, Rogatto SR, Achatz MI, MacDonald DJ.

J Nurs Scholarsh. 2013 Mar;45(1):43-51. doi: 10.1111/j.1547-5069.2012.01465.x. Epub 2013 Jan 7. Review.

PMID:
23294839
14.

Enhancement of Plant Productivity in the Post-Genomics Era.

Thao NP, Tran LS.

Curr Genomics. 2016 Aug;17(4):295-6. doi: 10.2174/138920291704160607182507.

15.

Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects.

Shoaib M, Rameez MA, Hussain SA, Madadin M, Menezes RG.

Sci Eng Ethics. 2016 Nov 28. [Epub ahead of print]

PMID:
27896605
16.

Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine.

Audenet F, Yates DR, Cancel-Tassin G, Cussenot O, Rouprêt M.

BJU Int. 2012 Jun;109(12):1864-70. doi: 10.1111/j.1464-410X.2011.10661.x. Epub 2011 Oct 28. Review.

17.

Getting personal: Head and neck cancer management in the era of genomic medicine.

Birkeland AC, Uhlmann WR, Brenner JC, Shuman AG.

Head Neck. 2016 Apr;38 Suppl 1:E2250-8. doi: 10.1002/hed.24132. Epub 2015 Aug 13. Review.

18.

Personalized therapy for breast cancer.

De Abreu FB, Schwartz GN, Wells WA, Tsongalis GJ.

Clin Genet. 2014 Jul;86(1):62-7. doi: 10.1111/cge.12381. Epub 2014 Apr 9. Review.

PMID:
24635704
19.

Genomic medicine and risk prediction across the disease spectrum.

Kotze MJ, Lückhoff HK, Peeters AV, Baatjes K, Schoeman M, van der Merwe L, Grant KA, Fisher LR, van der Merwe N, Pretorius J, van Velden DP, Myburgh EJ, Pienaar FM, van Rensburg SJ, Yako YY, September AV, Moremi KE, Cronje FJ, Tiffin N, Bouwens CS, Bezuidenhout J, Apffelstaedt JP, Hough FS, Erasmus RT, Schneider JW.

Crit Rev Clin Lab Sci. 2015;52(3):120-37. doi: 10.3109/10408363.2014.997930. Epub 2015 Jan 19. Review.

PMID:
25597499
20.

Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis.

Ward S, Scope A, Rafia R, Pandor A, Harnan S, Evans P, Wyld L.

Health Technol Assess. 2013 Oct;17(44):1-302. doi: 10.3310/hta17440. Review.

Supplemental Content

Support Center